This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Other. Active years: 2017.
Company Filing History:
1 out of 834,411 Years Active: 2017
Title: Innovations of Markus Mobs in Parvovirus Research
Introduction
Markus Mobs is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of virology, particularly through his work on parvovirus B19. His innovative approach has led to advancements in understanding and manipulating viral proteins.
Latest Patents
Markus Mobs holds a patent for a modified VP1-capsid protein of parvovirus B19. This invention relates to a modified VP1-capsid protein that exhibits reduced phospholipase A2-like enzyme activity compared to the wild type VP1-capsid protein. The amino acid sequence of this modified protein is detailed in SeqID 1. This patent represents a significant step forward in the study of parvoviruses and their potential applications.
Career Highlights
Throughout his career, Markus Mobs has focused on the intricate mechanisms of viral proteins. His research has not only contributed to the scientific community but has also opened new avenues for therapeutic interventions. His dedication to innovation in this field is evident through his patent and ongoing research efforts.
Collaborations
Markus has collaborated with esteemed colleagues such as Susanne Modrow and Torsten Lowin. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Markus Mobs is a prominent figure in the field of virology, with a focus on parvovirus B19. His patented innovations and collaborative efforts highlight his commitment to advancing scientific knowledge. His work continues to inspire future research in viral studies.